🇬🇧Stalecollected in 31m

Colossal Claims Dire Wolf De-Extinction

Colossal Claims Dire Wolf De-Extinction
PostLinkedIn
🇬🇧Read original on The Guardian Technology

💡$10.2B valuation on de-extinction: funding lessons & ethics for AI founders in emerging tech.

⚡ 30-Second TL;DR

What Changed

Valued at $10.2bn after raising hundreds of millions from celebrity investors including Tiger Woods and Paris Hilton

Why It Matters

Showcases massive funding potential for synthetic biology startups akin to AI ventures, but raises ethical debates on prioritizing de-extinction over current conservation that tech founders should consider.

What To Do Next

Study Colossal's funding deck for tactics to pitch AI-biotech hybrid startups to celebrity VCs.

Who should care:Founders & Product Leaders

Key Points

  • Valued at $10.2bn after raising hundreds of millions from celebrity investors including Tiger Woods and Paris Hilton
  • Announced de-extinction of dire wolf extinct >10,000 years via birth of three pups last year
  • Targeting dodo resurrection; CEO sees moral obligation, critics call it hype undermining conservation efforts

🧠 Deep Insight

Background and context from public sources — not the original article. 8 sources cited.

🔑 Enhanced Key Takeaways

  • The three dire wolf pups—Romulus, Remus, and Khaleesi—are genetically modified gray wolves with edits at 20 loci across 14 genes using CRISPR to replicate dire wolf phenotype[2][7][8].
  • Colossal developed a novel non-invasive cloning technique from blood draws, applied to clone four critically endangered red wolves to address genetic bottlenecks[1][3][7].
  • The project faced criticism including a 2025 'Screamers Award' for science hype and claims it's not true de-extinction or conservation per IUCN SSC guidelines[2][5].
  • Pups will reside on a 2,000-acre fenced preserve without wild reintroduction, and North Dakota invested to aid bison conservation[1][3].

🛠️ Technical Deep Dive

  • Utilized advanced multiplex CRISPR-based gene editing to introduce precise modifications at 20 loci across 14 genes in gray wolf embryos for dire wolf phenotypic replication[8].
  • Developed novel non-invasive cloning from blood cells/draws, avoiding traditional tissue methods, enabling red wolf cloning[7][8].
  • Produced genetically engineered gray wolves (Canis lupus) as proxies, not pure dire wolves (Aenocyon dirus), surviving infancy[2].

🔮 Future ImplicationsAI analysis grounded in cited sources

Colossal's gene editing tools will clone at least 10 more red wolves by 2027
Techniques from dire wolf project already cloned four red wolves to combat genetic bottlenecks, with CEO stating intent for broader endangered species applications[1][3][7].
De-extinction tech boosts human healthcare via animal genome datasets
Research generates datasets for drug development and health challenges, analogous to NASA spin-offs[6].
IUCN-aligned proxies fail to restore ecosystems without niches
Critics note proxies do not meet IUCN SSC guidelines or contribute to conservation due to absent ecological roles[2].

Timeline

2022-10
Unveiled thylacine de-extinction program, sequencing full Tasmanian tiger genome
2024-10
Announced first dire wolf de-extinction success with birth of pups Romulus, Remus, Khaleesi
2025-04
Publicized dire wolf revival and red wolf cloning in media coverage
2025-11
Faced criticism labeling dire wolf resurrection as phony despite tech potential
2025-12
Won 'The Screamers Award' for science hype on dire wolf claims
📰

Weekly AI Recap

Read this week's curated digest of top AI events →

👉Related Updates

AI-curated news aggregator. All content rights belong to original publishers.
Original source: The Guardian Technology

This is a summary, not the original. Read the source, or get the weekly briefing.

Weekly AI briefing

One email a week. Unsubscribe anytime.